Entrada Therapeutics
TRDA
TRDA
83 hedge funds and large institutions have $423M invested in Entrada Therapeutics in 2024 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 42 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 77 → 83 (+6)
2.44% more ownership
Funds ownership: 77.46% → 79.9% (+2.4%)
Holders
83
Holding in Top 10
4
Calls
$1K
Puts
–
Top Buyers
| 1 | +$23.7M | |
| 2 | +$22.1M | |
| 3 | +$5.43M | |
| 4 |
BlackRock
New York
|
+$2.96M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.91M |
Top Sellers
| 1 | -$10.3M | |
| 2 | -$1.3M | |
| 3 | -$834K | |
| 4 |
Citigroup
New York
|
-$723K |
| 5 |
WG
Winton Group
London,
United Kingdom
|
-$461K |